Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

E-Cigarettes Could Up Respiratory Infection Risk

Vapor from electronic cigarettes may increase young people's risk of respiratory infections, regardless of whether or not it contains nicotine.

Aspirin-Exacerbated Respiratory Disease

Although previous numbers for aspirin-exacerbated respiratory disease (AERD) have varied widely, new findings suggest that it is present in approximately 7% of the adult asthmatic patient population, with that number doubled in patients with severe asthma.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Lung Infections May Hamper Cancer Detection

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common.

Fetal BPA Exposure and Childhood Wheeze

Exposure in pregnancy to bisphenol A (BPA) may increase a child's risk of respiratory issues, with a 10-fold increase in the average amount of BPA in the mothers' urine linked to a nearly 55% increase in the odds of some type of wheezing in their children.

Asthma Risk and Job Loss Fear

Perceived job insecurity during an economic downturn may increase the risk of newly onset asthma.

Sense of Smell May Predict Mortality

Olfaction could predict 5-year mortality risk among older adults, suggests a new study.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.


Pulmozyme with eRapid Nebulizer Use Approved for CF

The Food and Drug Administration (FDA) has approved PARI's eRapid Nebulizer System (eRapid), the first electronic nebulizer to deliver Pulmozyme (dornase alfa [recombinant human DNase]; Genentech) for the treatment of cystic fibrosis.

Tools for COPD Diagnosis Evaluated in Two Studies

Two studies published in the Annals of Family Medicine evaluate the tools available for diagnosis of chronic obstructive pulmonary disease (COPD).

New Inhalers for Asthma, COPD Launched

GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation powder).

New Spiriva Inhalation Formulation Now Available

Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) Inhalation Spray is now available.

Featured courses from mycme

Achieving and Sustaining Asthma Control in the Community SettingExternal web site

In this activity, experts will review the role of inflammation in both the large and ...

CME|CPE|CE 1.50 Credits

Asthma and COPD: Providing Optimal Management (Pharmacology Credit)External web site

This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...

CE 1.50 Credits

Sign Up for Free e-newsletters